Company Atrinsic, Inc. Other OTC
Equities
US04964C2089
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
|
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Alexander Arrow
DFI | Director of Finance/CFO | 53 | 16-01-31 |
Andrew Slee
COO | Chief Operating Officer | 74 | 16-03-31 |
Robert Stein
CTO | Chief Tech/Sci/R&D Officer | 73 | 16-02-11 |
Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Garo Armen
FOU | Founder | 71 | 94-02-02 |
Robert Stein
CTO | Chief Tech/Sci/R&D Officer | 73 | 16-02-11 |
Brian Corvese
BRD | Director/Board Member | 67 | 17-07-27 |
Khalil Barrage
BRD | Director/Board Member | 59 | 07-06-30 |
Timothy Wright
BRD | Director/Board Member | 66 | 22-11-22 |
Jennifer Buell
BRD | Director/Board Member | 49 | 20-07-17 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 4,435,132 | 3,466,915 ( 78.17 %) | 0 | 78.17 % |
Company contact information
Protagenic Therapeutics, Inc.
149 Fifth Avenue Suite 500
10010, New York
+212 994 8200
http://www.protagenic.com![address Atrinsic, Inc.](https://cdn.zonebourse.com/static/address/9355004.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+23.17% | 45.01B | |
+47.19% | 40.96B | |
-5.58% | 38.62B | |
+36.36% | 32.6B | |
-7.79% | 27.49B | |
+18.38% | 27.17B | |
+48.76% | 14.61B | |
+41.54% | 12.95B | |
-1.71% | 11.36B |
- Stock Market
- Equities
- PTIX Stock
- Stock
- Company Atrinsic, Inc.